Characterization of monoclonal antibody B7, which neutralizes the cytotoxicity of Pseudomonas aeruginosa exotoxin A

Clinical and Diagnostic Laboratory Immunology

Volumn 3, Issue 6, 1996, Pages 727-732

  Shang, Huey Fang ^a,b,c   Yeh, Mei Ling ^d   Lin, Chia P O ^d   Hwang, Jaulang ^c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^d DEPARTMENT OF HEALTH   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; PSEUDOMONAS EXOTOXIN;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ANIMAL EXPERIMENT; ARTICLE; CYTOTOXICITY; EPITOPE MAPPING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; PSEUDOMONAS AERUGINOSA;

EID: 0029909695     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.3.6.727-732.1996     Document Type: Article

References (29)

1. Bodey, G. P., R. Bolivar, V. Fainstein, and L. Jadeja. 1983. Infections caused by Pseudomonas aeruginosa. Rev. Infect. Dis. 5:279-313.
2. Bourdenel, S., M. J. Vacheron, M. Guinand, G. Michel, and F. Arminjon. 1990. Biochemical and immunochemical studies of proteolytic fragments of exotoxin A from Pseudomonas aeruginosa. Eur. J. Biochem. 192:379-385.
3. Chaudhary, V. K., Y. Jinno, D. FitzGerald, and I. Pastan. 1990. Pseudomonas exotoxin contains a specific sequence at the carboxyl terminus that is required for cytotoxicity. Proc. Natl. Acad. Sci. USA 87:308-312.
4. Chia, J. K. S., M. Pollack, D. Avigan, and S. Steinbach. 1986. Functionally distinct monoclonal antibodies reactive with enzymatically active and binding domains of Pseudomonas aeruginosa exotoxin. Infect. Immun. 52:756-762.
5. Chow, J. T., M. S. Chen, H. C. P. Wu, and J. Hwang. 1989. Identification of the carboxy-terminal amino acids important for the ADP-ribosylation activity of pseudomonas exotoxin A. J. Biol. Chem. 264:18818-18823.
6. Cross, A. S., J. C. Sadoff, B. H. Iglewski, and P. A. Sokol. 1980. Evidence for the role of toxin A in the pathogenesis of infection with Pseudomonas aeruginosa in humans. J. Infect. Dis. 142:538-546.
7. Cryz, S. J., Jr. 1984. Pseudomonas aeruginosa infections, p. 317-351. In R. Germanier (ed.)m Bacterial vaccines. Academic Press, Inc., Orlando, Fla.
8. de St. Groth, S. F., and D. Scheidegger. 1980. Production of monoclonal antibodies: strategy and tactics. J. Immunol. Methods 35:1-21.
9. Douglas, C. M., and R. J. Collier. 1987. Exotoxin A of Pseudomonas aeruginosa: substitution of glutamic acid 553 with aspartic acid dramatically reduces toxicity and enzymatic activity. J. Bacteriol. 169:4967-4971.
10. FitzGerald, D., R. E. Morris, and C. B. Saelinger. 1980. Receptor-mediated internalization of Pseudomonas toxin by mouse fibroblasts. Cell 21:867-873.
11. Galloway, D. R., R. C. Hdestrom, and O. R. Pavlovskis. 1984. Production and characterization of monoclonal antibodies to exotoxin A from Pseudomonas aeruginosa. Infect. Immun. 44:262-267.
12. Hancock, R. E. W. 1986. Intrinsic antibiotic resistance of Pseudomonas aeruginosa. J. Antimicrob. Chemother. 18:653-656.
13. Hwang, J., and M. S. Chen. 1989. Structure and function relationship of Pseudomonas exotoxin A. J. Biol. Chem. 264:2379-2384.
14. Hwang, J., D. J. FitzGerald, S. Adhya, and I. Pastan. 1987. Functional domains of pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli. Cell 48:129-136.
15. Iglenski, B. H., and D. Kabat. 1975. NAD-dependent inhibition of protein synthesis by Pseudomonas aeruginosa toxin A. Proc. Natl. Acad. Sci. USA 77:2284-2288.
16. 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes pseudomonas exotoxin A. J. Biol. Chem. 267:12420-12423.
17. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680-685.
18. Lee, C. H., E. C. Lee, S. T. Tsai, H. J. Kung, Y. C. Liu, and J. Hwang. 1993. An EGF-pseudomonas exotoxin A recombinant protein with a deletion in toxin binding domain specifically kills EGF receptor bearing cells. Protein Eng. 6:433-440.
19. Liao, C. W., T. H. Hseu, and J. Hwang. 1995. A target-specific chimeric toxin composed of epidermal growth factor and Pseudomonas exotoxin A with a deletion in its toxin-binding domain. Appl. Microbiol. Biotechnol. 43:498-507.
20. Nicas, T. I., and B. H. Iglenski. 1985. The contribution of exoproducts to virulence of Pseudomonas aeruginosa. Can. J. Microbiol. 31:387-392.
21. Ogata, M., V. K. Chaudhary, I. Pastan, and D. J. FitzGerald. 1990. Processing of pseudomonas exotoxin by a cellular protease results in the generation of a 37,000-Da toxin fragment that is translocated to the cytosol. J. Biol. Chem. 265:20678-20685.
22. Ohtsuka, H., K. Horigome, A. Higuchi, N. Normura, H. Ochi, S.-I. Yokota, T. Kohzuki, and H. Noguchi. 1992. Binding of monoclonal antibody specific for domain Ia/II of Pseudomonas aeruginosa exotoxin A at pH 4 strongly neutralizes exotoxin A-induced cytotoxicity in cell culture and in vivo. Infect. Immun. 60:1061-1068.
23. Ohtsuka, H., K. Horigome, H. Ochi, T. Nishimoto, T. Kohzuki, M. Kato, T. Okuda, and H. Noguchi. 1991. Production and characterization of human monoclonal antibody recognizing the N-terminal residues of Pseudomonas aeruginosa exotoxin A. Hybridoma 20:297-307.
24. Orlandi, R., D. H. Gussow, P. T. Jones, and G. Winter. 1989. Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. Proc. Natl. Acad. Sci. USA 86:3833-3837.
25. Pollack, M. 1983. The role of exotoxin A in Pseudomonas disease and immunity. Rev. Infect. Dis. 5(Suppl.):S979-S984.
26. Pollack, M., and R. K. Prescott. 1982. Toxoid from exotoxin A of Pseudomonas aeruginosa: preparation and characterization. J. Infect. Dis. 145:688-698.
27. Voller, A., D. E. Bidnell, and A. Bartlett. 1979. The enzyme linked immunosorbent assay (ELISA). Dynatech Laboratories, Alexandria, Va.
28. Winter, G., and W. J. Harris. 1993. Humanized antibodies. Immunol. Today 14:243-246.
29. Wozniak, D. J., L. Y. Hsu, and D. R. Galloway. 1988. His-426 of Pseudomonas aeruginosa exotoxin A is required for ADP-ribosylation of elongation factor II. Proc. Natl. Acad. Sci. USA 85:8880-8884.